Home

Jason O'Byrne

CIK 1871145 · CHIEF FINANCIAL OFFICER · last filed 2026-09-02

Jason O'Byrne is a CHIEF FINANCIAL OFFICER who has filed 19 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for VIR, was dated Sep 17, 2026. Across all open-market trades the lifetime net is −$68.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions. 5 SEC filings were submitted jointly with Caribou Biosciences, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.88M

Companies

3

Total Filings

19

Lifetime Open-Market Net

-$68.9K

Filer Profile

Reported Address
VIR BIOTECHNOLOGY, INC.
1800 OWENS ST., SUITE 900
SAN FRANCISCO, CA 94158
Related Filers
Caribou Biosciences, Inc. — 5 joint filings, latest 2024-02-22
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OLMA CHIEF FINANCIAL OFFICER — $8.83 — $0 1 2026-09-02
VIR EVP & Chief Financial Officer 162,615 $11.09 $1.80M -$68.9K 6 2026-03-23
CRBU Chief Financial Officer 59,224 $1.29 $76.4K $0 4 2024-02-22

Recent Filings

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-17 VIR Notice (144) −19,357 -$212.9K EDGAR
2026-09-09 VIR Notice (144) −28,333 -$315.2K EDGAR
2026-09-02 OLMA Grant (A) — $0 EDGAR
2026-08-25 VIR Notice (144) −23,148 -$242.6K EDGAR
2026-08-24 VIR Notice (144) −14,352 -$142.1K EDGAR
2026-08-21 VIR Notice (144) −25,000 -$245.3K EDGAR
2026-03-23 VIR Other (J) — $0 EDGAR
2026-02-26 VIR Sell (S) −1,634 -$15.6K EDGAR
2026-02-24 VIR Notice (144) −1,634 -$15.6K EDGAR
2026-02-24 VIR Mixed +52,911 -$15.6K EDGAR
Showing 1–10 of 19
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.